Nucleix Strengthens Leadership and Expands Footprint for U.S. Growth of Liquid Biopsy Development
SAN DIEGO & REHOVOT, Israel–(BUSINESS WIRE)–Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced the expansion of its operations into the United States and the appointment of new executive and board leadership to support future growth.
Subscribe to one of our social media channels
Subscription Confirmation Required
Go to your email inbox
Go to the inbox of the email address you just used to sign up.
Open the confirmation email
Find the email sent by us. It has the subject line “Nucleix: Please Confirm Subscription” and I sent from “firstname.lastname@example.org”.
Click the confirmation link
Click on the link inside the email and you’re good to go.